CCS Unveils New Research at ISPOR 2026: Longitudinal Coaching and Education Sustain CGM Outcomes Beyond Initiation

ST. PETERSBURG, Fla.--(BUSINESS WIRE)--As healthcare providers and health plans grapple with growing continuous glucose monitoring (CGM) adoption and persistent gaps in diabetes outcomes alongside growing chronic care costs, a new research-driven poster from CCS is challenging the assumption that simply being prescribed a CGM device is enough. While CGM initiation is often associated with early improvements in glycemic control, new research from CCS suggests those improvements are not consistently sustained without ongoing support.

At ISPOR 2026, taking place May 17–20 at the Pennsylvania Convention Center in Philadelphia, CCS will offer a poster presentation entitled, Effect of Structured Coaching and Education on Glycemic and Patient-Reported Outcomes Among Adults Initiating CGM: A Randomized Study.

This poster showcases soon to be published research highlighting the impact of LivingConnected^®, a DEAP-accredited program delivering coaching and education for adults starting CGM. The randomized trial enrolled 424 adults new to CGM, comparing standard CGM initiation alone with CGM paired with a nine-month, remote, CDCES-led education and coaching program.

Findings reinforce that CGM is a powerful starting point, but not a complete solution on its own. Key insights include:

• Sustained Blood Sugar Control: CGM users with structured support experienced a statistically significant reduction in mean blood glucose over nine months (P = 0.047).
• Greater Confidence in Self-Management: Participants in the coaching program reported significantly higher confidence managing their diabetes (P < 0.05), a key driver of long-term adherence and improved outcomes.
• Scalable Remote Model: Delivered entirely remotely, the program offers an accessible, practical way to extend and sustain CGM effectiveness.

“Continuous glucose monitoring provides powerful insights, but access to data alone is not enough to sustain behavior change,” said Coni Dennis, DNP, RN, NE-BC, SVP and Chief Clinical Officer at CCS. “We often see early improvements following CGM initiation, but without ongoing support, that improvement doesn’t always last. Coaching and education help people build confidence in how patients manage day to day, and turn personal health data into habits they can sustain over time.”

With nearly 40 million Americans living with diabetes, the data underscores the critical role of human-led education and coaching in achieving better outcomes and reducing the high costs associated with preventable complications. Sustained engagement, not just device access, is essential to maximizing the value of CGM therapy.

Given that preventable diabetes complications — hospitalizations, ER visits, and downstream comorbidities — cost the U.S. an estimated $412.9 billion in direct medical and economic costs annually, the study's findings carry direct implications for how the U.S. can and should redesign care management programs to pair CGM technology with longitudinal, high-value education and coaching that drives long-term, reliable outcomes.

About CCS

CCS is the strategic partner addressing America’s most pressing healthcare challenges through intelligent chronic care management, tackling the $412 billion annual diabetes burden and chronic conditions affecting over 133 million Americans. At the core of CCS’s differentiated model is LivingConnected^®, a human-led, digitally enabled clinical solution. PropheSee™ — an AI-powered predictive model that identifies nonadherence risk and delivers personalized interventions — is an integral part of this solution, creating a first-of-its-kind platform to improve adherence, enhance clinical outcomes, and help prevent costly hospitalizations. By combining data-driven insights with three decades of industry relationships, CCS is the smart choice for health plans, providers, employers, and manufacturers who believe that value-based care starts by keeping patients healthy and delivers benefits like lower cost of care, improved HEDIS scores, and alleviating provider burnout. CCS’s approach extends clinical reach while supporting over 200,000 people nationwide with home-delivered medical supplies and pharmaceuticals annually. Recognized as a Great Place to Work^® and with several peer-reviewed publications validating our care management approach, CCS is more than a trusted supplier — we’re a partner in transforming chronic care delivery. To learn more about how CCS is addressing today’s healthcare challenges, visit CCSMed.com or connect with us on LinkedIn.